# Corticosteroid Therapy for Severe Community-Acquired Pneumonia

> **NCT02552342** · PHASE4 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 610 (estimated)

## Conditions studied

- Community Acquired Pneumonia

## Interventions

- **DRUG:** methylprednisolone
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT02552342
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 610 (ESTIMATED)
- **Last updated:** 2015-09-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02552342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02552342, "Corticosteroid Therapy for Severe Community-Acquired Pneumonia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02552342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*